Brief: Sinomab Bioscience Says Ind Approval For Sn1011 By China's Nmpa
20/04/2022 12:29
April 20 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* IND APPROVAL FOR SN1011 BY CHINA'S NMPA
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience